Intercept Pharmaceuticals, Inc.
NASDAQ:ICPT
Overview | Financials
Company Name | Intercept Pharmaceuticals, Inc. |
Symbol | ICPT |
Currency | USD |
Price | 19 |
Market Cap | 794,694,000 |
Dividend Yield | 0% |
52-week-range | 8.82 - 21.86 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Jerome B. Durso |
Website | https://www.interceptpharma.com |
An error occurred while fetching data.
About Intercept Pharmaceuticals, Inc.
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination with ursodeoxycholic acid in
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD